graves ophthalmopathy
Showing NaN - NaN of 5
Graves Ophthalmopathy Trial in Pisa (Sirolimus)
Not yet recruiting
- Graves Ophthalmopathy
-
Pisa, ItalyOspedale Cisanello-Endocrinology II
Nov 2, 2022
Graves Ophthalmopathy Trial in Italy (Tocilizumab 20 Mg/mL Intravenous Solution, MethylPREDNISolone Injectable Solution)
Recruiting
- Graves Ophthalmopathy
- Tocilizumab 20 Mg/mL Intravenous Solution
- MethylPREDNISolone Injectable Solution
-
Milano, MI, Italy
- +3 more
Aug 3, 2022
Sirolimus in Graves' Orbitopathy
Completed
- Graves Ophthalmopathy
-
Pisa, PI, ItalyEndocrinologia II
Apr 19, 2022
Genetics and Epigenetics of Graves' Orbitopathy
Completed
- Graves Ophthalmopathy
- No Intervention
-
Pisa, ItalyOspedale Cisanello-Endocrinology I and II
Jul 22, 2020
Anti-insulin-like Growth Factor-1 Receptor Antibodies in Graves'
Completed
- Graves Ophthalmopathy
- +2 more
- Serum antibodies against the IGF-1R
-
Pisa, ItalyEndocrinology Unit I, University of Pisa
Jul 26, 2018